Capstan Therapeutics
StartupUS1 field
Where it works
| Technology | ||
|---|---|---|
| NanotechnologyBuilt targeted LNPs to make CAR-T cells inside the body; acquired by AbbVie in 2025. | Built targeted LNPs to make CAR-T cells inside the body; acquired by AbbVie in 2025. | sec.gov |
Events
| Date | Event | ||
|---|---|---|---|
| Jun 19, 2025 | Targeted LNPs generate CAR-T cells inside the bodydoi.org· Breakthrough· Nanotechnology | Nanotechnology | Breakthrough |
About
- Source
- sec.gov (filing, added by seed)
- First seen
- Sep 25, 2026
- Last seen
- Sep 25, 2026
| Date | Change | ||
|---|---|---|---|
| Sep 25, 2026 | Capstan TherapeuticsCompany in Nanotechnology: Joined a field, Built targeted LNPs to make CAR-T cells inside the body; acquired by AbbVie in 2025. | seed | sec.gov |
| Sep 25, 2026 | Capstan TherapeuticsCompany: Added | seed | sec.gov |